A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 94.02
GOOG 683.57
MSFT 50.16
FB 104.07
BAC 12.95

Recently Added

LYB 79.75
FANG 67.31
CXO 87.27
UPS 95.37
DAL 42.01

Gaining Speed

LYB 79.75
UPS 95.37
DAL 42.01
DG 71.66
JNJ 100.54

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More

Get Alerted When News Hits On This Stock - FREE!